T2 Biosystems, Inc. (TTOO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1161965,
    "name": "T2 Biosystems, Inc.",
    "stock_name": "T2 Biosystems, Inc.",
    "full_name": "T2 Biosystems, Inc.",
    "name_url": "stocks-analysis/t2-biosystems-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.01",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "0.01",
    "mcapval": "0.34",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US89853L3024",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "28.16 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/t2-biosystems-inc-1161965-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is T2 Biosystems, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-t2-biosystems-inc-technically-bullish-or-bearish-3546856",
        "imagepath": "",
        "date": "2025-09-20 19:41:51",
        "description": "As of 25 August 2025, the technical trend for T2 Biosystems, Inc. has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish, indicating some positive momentum. The monthly RSI shows a bullish signal, but the daily moving averages remain bearish, suggesting short-term weakness. The Bollinger Bands are sideways on the weekly chart and mildly bearish on the monthly chart, indicating a lack of clear direction. KST is bearish on both weekly and monthly time frames, and Dow Theory shows no trend in either time frame.\n\nIn terms of performance, T2 Biosystems has significantly underperformed the S&P 500 across all periods, with a year-to-date return of -99.17% compared to the S&P 500's 12.22%. This stark contrast highlights the ongoing challenges faced by the stock. Overall, the current technical stance is mildly bearish, with mixed signals across di..."
      },
      {
        "title": "Is T2 Biosystems, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-t2-biosystems-inc-overvalued-or-undervalued-3543341",
        "imagepath": "",
        "date": "2025-09-20 18:16:53",
        "description": "As of 8 July 2024, the valuation grade for T2 Biosystems, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company is overvalued given its negative valuation ratios, including a price to book value of -0.36 and an EV to EBITDA of -0.38, both of which suggest substantial financial distress. Additionally, its peer comparison reveals that T2 Biosystems underperforms against competitors like Vicarious Surgical, Inc. with an EV to EBITDA of -0.2398 and Citius Pharmaceuticals, Inc. at -0.3855.\n\nThe stock has experienced drastic declines, with a year-to-date return of -99.17% compared to the S&P 500's positive return of 12.22%, further reinforcing the notion that T2 Biosystems is not only overvalued but also facing severe operational challenges...."
      }
    ],
    "total": 6,
    "sid": "1161965",
    "stock_news_url": "https://www.marketsmojo.com/news/t2-biosystems-inc-1161965"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is T2 Biosystems, Inc. technically bullish or bearish?

2025-09-20 19:41:51

As of 25 August 2025, the technical trend for T2 Biosystems, Inc. has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish, indicating some positive momentum. The monthly RSI shows a bullish signal, but the daily moving averages remain bearish, suggesting short-term weakness. The Bollinger Bands are sideways on the weekly chart and mildly bearish on the monthly chart, indicating a lack of clear direction. KST is bearish on both weekly and monthly time frames, and Dow Theory shows no trend in either time frame. In terms of performance, T2 Biosystems has significantly underperformed the S&P 500 across all periods, with a year-to-date return of -99.17% compared to the S&P 500's 12.22%. This stark contrast highlights the ongoing challenges faced by the stock. Overall, the current technical stance is mildly bearish, with mixed signals across di...

Is T2 Biosystems, Inc. overvalued or undervalued?

2025-09-20 18:16:53

As of 8 July 2024, the valuation grade for T2 Biosystems, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company is overvalued given its negative valuation ratios, including a price to book value of -0.36 and an EV to EBITDA of -0.38, both of which suggest substantial financial distress. Additionally, its peer comparison reveals that T2 Biosystems underperforms against competitors like Vicarious Surgical, Inc. with an EV to EBITDA of -0.2398 and Citius Pharmaceuticals, Inc. at -0.3855. The stock has experienced drastic declines, with a year-to-date return of -99.17% compared to the S&P 500's positive return of 12.22%, further reinforcing the notion that T2 Biosystems is not only overvalued but also facing severe operational challenges....

View All News